Sol-Gel Technologies Ltd. ( SLGL) - Key Metrics
SLGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.18 | -$1.13 | $0 | $0 |
| 2026Q1 | $0.04 | -$1.31 | $0 | $0 |
| 2025Q4 | $0.25 | -$1.07 | $0 | $0 |
| 2025Q3 | $0.14 | -$2.13 | $0 | $0 |
| 2025Q2 | $6.20 | $4.17 | $0 | $0 |
SLGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -16.40 |
| 2026Q1 | 0% | -15.12 |
| 2025Q4 | 0% | -9.85 |
| 2025Q3 | 0% | -3.42 |
| 2025Q2 | 0% | 0.44 |
SLGL
Price: $65.94
52 week price:
Earnings Per Share: -5.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 22900
Market Capitalization: 227.3 million